Skip to main content

HubXchange

HubXChange logo

AI in Drug Discovery Xchange - San Francisco - 2025

Page Banner 1

  1. Drug Design & Modeling
    • Drug Design & Modeling
    From Model to Molecule: Accelerating GPCR Drug Discovery with AI, Novel Chemistry, and Under explored Biology
    AI for GPCR Drug Discovery: What’s Working, What’s Missing? In Silicon to In Vivo: Translating AI Pr ...
    Caitlyn Krebs
    Caitlyn Krebs, Co-Founder & CEO - Nalu Bio
  2. Lead Generation & Optimization
    • Lead Generation & Optimization
    Evolving role of AI in navigating the transition from Hit Identification to Lead Optimization
    Kyle Giesler
    Kyle Giesler, Co-Founder & CSO - InFocus Therapeutics
  3. Drug Response Prediction
    • Data Quality
    • Target Identification
    • Drug Response Prediction
    • Drug Design & Modeling
    Poster Presentation:
  4. Drug Design & Modeling
    • Drug Design & Modeling
    Poster Presentation:
  5. Drug Design & Modeling
    • Drug Design & Modeling
    Sponsor Led Roundtable
  6. Drug Response Prediction
    • Drug Response Prediction
    Sponsor Led Roundtable:
  7. Drug Design & Modeling
    • Drug Design & Modeling
    AI for predicting protein-ligand and protein-protein interactions
    AI’s role in predicting molecular interactions for drug discovery. Integration of sequence and struc ...
    Venkatesh Mysore
    Venkatesh Mysore, CTO | Co-Founder | Head of AI - Aikium Inc. (for Protein Therapeutics)
  8. Drug Response Prediction
    • Drug Response Prediction
    Predicting Clinical Success: AI Models for Drug Response and Patient Stratification in Phase 2/3 Trials (Topic TBC)
    Lloyd L. Tran
    Lloyd L. Tran, Chairman & CEO - Biomed Industries Inc
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    1-2-1 Meetings / Networking Break
  10. Data Quality
    • Data Quality
    Poster Presentation:
  11. Target Identification
    • Target Identification
    Poster Presentation:
  12. Drug Response Prediction
    • Drug Response Prediction
    Training AI models on cell line and patient-derived data to improve response prediction
    Impact of biologically diverse data on model accuracy and robustness. Differences in predictive valu ...
    Paul Shi
    Paul Shi, Scientific Associate Director of Computational Biology - Amgen
  13. Lead Generation & Optimization
    • Lead Generation & Optimization
    Use of AI to reduce timeline of lead generation to optimization
    AI-driven acceleration of hit identification and lead prioritization. Use of predictive modeling to ...
    Daniel Haders II, Ph.D,
    Daniel Haders II, Ph.D,, CEO - Model Medicines
  14. Lead Generation & Optimization
    • Lead Generation & Optimization
    Poster Presentation: DrugBank

    Drugbank

    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    Drinks-Canape Reception
  16. Target Identification
    • Target Identification
    Using transcriptomics and single-cell data to uncover novel therapeutic targets

      

    Olivier Nolan-Stevaux, Ph.d,
    Olivier Nolan-Stevaux, Ph.d,, Senior Director, Oncology Research - Gilead Sciences, Inc.
  17. Data Quality
    • Data Quality
    Integrating Protein Structure Prediction into AI Pipelines: Ensuring Data Quality for Reliable Drug Discovery
    Ho Leung Ng
    Ho Leung Ng, CEO - Rise Bio
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    Registration
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    Spotlight Presentation: CDD Vault'
    Spotlight Presentation: CDD Vault'
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    1-2-1 Meetings / Networking Break
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    1-2-1 Meetings / Networking Break
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    Networking Lunch
  23. Target Identification
    • Target Identification
    • Drug Design & Modeling
    Sponsor Led Roundtable

    Elsevier

  24. Lead Generation & Optimization
    • Lead Generation & Optimization
    Sponsor-Led Roundtable
  25. Data Quality
    • Data Quality
    Sponsor Led Roundtable: Digital Science

    Digital Science

    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    Morning Refreshments
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    1-2-1 Meetings / Networking Break
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    1-2-1 Meetings / Networking Break
  29. Target Identification
    • Target Identification
    Applying AI to prioritize targets based on disease relevance and druggability
    Sushant Malhotra
    Sushant Malhotra, Vice President, Drug Discovery - Lyterian Therapeutics
  30. Data Quality
    • Data Quality
    Improving AI outcomes by standardizing data annotation across discovery platforms
    Ning Wang
    Ning Wang, Founder & CEO - Decode Origin
    • Data Quality
    • Target Identification
    • Lead Generation & Optimization
    • Drug Response Prediction
    • Drug Design & Modeling
    Opening Address & Keynote Presentation:
    Opening Address & Keynote Presentation:
Search